Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cellsAmir Hossein Daneshmanesh, H Mellstedt, Mohammad Hojjat‐Farsangi et al.|Leukemia|2012Cited by 104
The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapyMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Seminars in Cancer Biology|2014Cited by 99
Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignanciesAmir Hossein Daneshmanesh, Anders Österborg, Anna Porwit et al.|Leukemia & lymphoma/Leukemia and lymphoma|2012Cited by 83
The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Abdul Salam Khan et al.|PLoS ONE|2013Cited by 60
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Charlotta Löfberg et al.|Leukemia|2018Cited by 52